Meeting: 2017 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: 4001 Citation: J Clin Oncol 35, 2017 (suppl; abstr 4001) Authors: Ann-Lii Cheng, Richard S. Finn, Shukui Qin, et al. Background: SOR is the only approved agent in uHCC and new options are needed. LEN, an inhibitor of vascular...
Pro zobrazení tohoto obsahu je třeba být přihlášen.